TrialAtlas: Multi-Agent Research Organization for Clinical Trial Design and Optimization
Mirrored from arXiv — NLP / Computation & Language for archival readability. Support the source by reading on the original site.
Computer Science > Computation and Language
Title:TrialAtlas: Multi-Agent Research Organization for Clinical Trial Design and Optimization
Abstract:Nearly 90% of drugs entering clinical development ultimately fail, despite billions of dollars in investment. Pharmaceutical companies therefore rely on clinical development planning (CDP) and probability of technical and regulatory success assessment to anticipate development risks, yet these decisions remain labor-intensive and subjective, requiring experts across clinical science, statistics, regulatory affairs, and competitive intelligence to jointly acquire, synthesize, and reason over heterogeneous evidence. Here, we introduce TrialAtlas, a memory-augmented multi-agent research organization for CDP that mirrors this collaborative process by coordinating specialized agents for literature synthesis, competitive trial intelligence, regulatory precedent analysis, and integrated reasoning over trial design and development risk. TrialAtlas further learns from historical clinical trials and regulatory outcomes, including prior New Drug Applications (NDAs), to ground its decisions in accumulated development experience. To evaluate these capabilities in an authentic regulatory setting, we introduce TrialAtlasBench, constructed from 291 FDA Complete Response Letters and spanning three practical tasks: detecting trial design deficiencies, recommending actionable design improvements, and predicting technical and regulatory success. TrialAtlas achieves an F1 score of 50.0% for deficiency detection, outperforming the strongest baseline by 6.1 points, and reaches 85.3% balanced accuracy and 84.7% F1 for prediction of technical and regulatory success, improving over the best baselines by 6.7 points in balanced accuracy and 12.0 points in Cohen's kappa. In expert evaluation, 86.4% of TrialAtlas-generated concerns were judged valid, compared with 83.1% for OpenAI DeepResearch and 59.3% for Gemini DeepResearch.
| Subjects: | Computation and Language (cs.CL) |
| Cite as: | arXiv:2609.21859 [cs.CL] |
| (or arXiv:2609.21859v1 [cs.CL] for this version) | |
| https://doi.org/10.48550/arXiv.2609.21859
arXiv-issued DOI via DataCite (pending registration)
|
Access Paper:
- View PDF
- HTML (experimental)
- TeX Source
References & Citations
Bibliographic and Citation Tools
Code, Data and Media Associated with this Article
Demos
Recommenders and Search Tools
arXivLabs: experimental projects with community collaborators
arXivLabs is a framework that allows collaborators to develop and share new arXiv features directly on our website.
Both individuals and organizations that work with arXivLabs have embraced and accepted our values of openness, community, excellence, and user data privacy. arXiv is committed to these values and only works with partners that adhere to them.
Have an idea for a project that will add value for arXiv's community? Learn more about arXivLabs.
More from arXiv — NLP / Computation & Language
-
A Mechanistic Study of AI-Text Detection Neurons in Frozen BERT: Sparse Probing and Activation Patching on RAID
Sep 28
-
Manifold Projection and Iterative Autoencoder Refinement for Masked Language Modeling
Sep 28
-
Not All Memories Are Equal: Hierarchical Collaborative Memory for Validity-Aware Retrieval in LLM Agents
Sep 28
-
Auditing and Repairing LLM-as-Judge Failures in a Production Text-to-SQL Pipeline
Sep 28
Discussion (0)
Sign in to join the discussion. Free account, 30 seconds — email code or GitHub.
Sign in →No comments yet. Sign in and be the first to say something.